Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

Type 2 Inflammation Is The Underlying Cause Of Crswnp In 80% Of Patients.

Patient Case – Dupilumab in Atopic Dermatitis

Patient Case – Dupilumab in Atopic Dermatitis

What gives you confidence that Dupixent improves patients’ quality of life?

Innovation of Iglarlexi in Intensification

Innovation of Iglarlexi in Intensification

Innovation of Iglarlexi in Intensification

Innovation of Iglarlexi in Intensification

Innovation of Iglarlexi in Intensification

Innovation of Iglarlexi in Intensification